Based on the data, the per capita market value for Penicillins and Streptomycins in Brazil showed moderate fluctuations between 2013 and 2023 with a low of USD 1.82 in 2013 and a peak at USD 2.18 in 2018. In the latest data point for 2023, the value stood at USD 2.01. Notable year-on-year variations occurred between 2019 and 2021. Over the last two years, the market experienced nearly stable growth, aligning around a 0.5% increase between 2022 and 2023. The compound annual growth rate over the last five years indicates an average annual increase of 0.5%.
Looking ahead, future trends to monitor include potential impacts from emerging healthcare policies, antibiotic resistance challenges, and shifts in healthcare funding which might influence demand and value per capita. Additionally, ongoing advancements in alternative therapies could deter growth in this segment.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 22 | 22 South Africa | 2.34 | 2023 | View data | ||
| 23 | 23 Moldova | 2.19 | 2023 | View data | ||
| 24 | 24 Brazil | 2.01 | 2023 | |||
| 25 | 25 Malaysia | 1.87 | 2023 | View data | ||
| 26 | 26 Armenia | 1.75 | 2023 | View data | ||
